TRB Tribal Group plc
Tribal Group plc, through its subsidiaries, provides software and services to education institutions internationally. The company operates in two segments: Student Information Systems (SIS) and Etio. The Student Information Systems segment offers software, and subsequent maintenance and support services; and deploys and configures software solutions, asset management, software-related solutions for higher education and vocational learning, and information managed services for its customers. The Etio segment provides inspection and review services that support the assessment of educational delivery, as well as a portfolio of performance improvement tools and services, including analytics. It serves further and higher education institutions, employers, and school sectors, as well as work-based learning training providers. The company was founded in 1999 and is based in Sheffield, the United Kingdom.…
Industry Peers
Software - ApplicationKey Statistics
About Tribal Group (LON: TRB)
›
Tribal Group (LON: TRB) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Software - Application industry, part of the Technology sector, and reports about 919 employees.
The shares were at 101.50 GBp on 19 November 2026, up 63.8% over 52 weeks. Its 52-week range is 46.00 GBp to 104.00 GBp: the price is 2.4% below the high and 120.7% above the low.
At a market capitalisation of 217.60M GBP, it trades at 25.4 times trailing earnings and 22.6 times forward earnings. The median trailing P/E of its 17 largest Software - Application peers is 31.6, a discount of 20% for TRB. It pays a dividend yielding 1.27% (it pays out 32% of its earnings), against a median of 1.31% among the dividend payers in that peer group.
Tribal Group reports return on equity of 14.9%, an operating margin of 13.6% and revenue up 8.0% year over year.
Its debt exceeds its cash by 158.00K GBP, a debt-to-equity ratio of 0.02. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 100.00 GBp is 1.5% below the current price.